These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8843637)

  • 1. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan.
    Apostolopoulos V; Pietersz GA; McKenzie IF
    Vaccine; 1996 Jun; 14(9):930-8. PubMed ID: 8843637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice.
    Lees CJ; Apostolopoulos V; Acres B; Ramshaw I; Ramsay A; Ong CS; McKenzie IF
    Vaccine; 2000 Sep; 19(2-3):158-62. PubMed ID: 10930667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
    Apostolopoulos V; Xing PX; McKenzie IF
    Cancer Res; 1994 Oct; 54(19):5186-93. PubMed ID: 7923138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan.
    Vaughan HA; Ho DW; Karanikas V; Sandrin MS; McKenzie IF; Pietersz GA
    Vaccine; 2000 Aug; 18(28):3297-309. PubMed ID: 10869775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of humoral and cellular responses in cynomolgus monkeys immunised with mannan-human MUC1 conjugates.
    Vaughan HA; Ho DW; Karanikas VA; Ong CS; Hwang LA; Pearson JM; McKenzie IF; Pietersz GA
    Vaccine; 1999 Jun; 17(20-21):2740-52. PubMed ID: 10418926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.
    Apostolopoulos V; Pietersz GA; Loveland BE; Sandrin MS; McKenzie IF
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10128-32. PubMed ID: 7479739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection.
    Karanikas V; Thynne G; Mitchell P; Ong CS; Gunawardana D; Blum R; Pearson J; Lodding J; Pietersz G; Broadbent R; Tait B; McKenzie IF
    J Immunother; 2001; 24(2):172-83. PubMed ID: 11265775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a mucin-1 tumour antigen.
    Lofthouse SA; Apostolopoulos V; Pietersz GA; Li W; McKenzie IF
    Vaccine; 1997 Oct; 15(14):1586-93. PubMed ID: 9330472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
    Karanikas V; Hwang LA; Pearson J; Ong CS; Apostolopoulos V; Vaughan H; Xing PX; Jamieson G; Pietersz G; Tait B; Broadbent R; Thynne G; McKenzie IF
    J Clin Invest; 1997 Dec; 100(11):2783-92. PubMed ID: 9389743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1.
    Pietersz GA; Li W; Osinski C; Apostolopoulos V; McKenzie IF
    Vaccine; 2000 Apr; 18(19):2059-71. PubMed ID: 10706970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide enhances the CTL precursor frequency in mice immunized with MUC1-mannan fusion protein (M-FP).
    Apostolopoulos V; Popovski V; McKenzie IF
    J Immunother; 1998 Mar; 21(2):109-13. PubMed ID: 9551361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunogenicity of MUC1 peptides and fusion protein.
    Apostolopoulos V; Pietersz GA; Xing PX; Lees CJ; Michael M; Bishop J; McKenzie IF
    Cancer Lett; 1995 Mar; 90(1):21-6. PubMed ID: 7720038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity.
    Li D; Li H; Zhang P; Wu X; Wei H; Wang L; Wan M; Deng P; Zhang Y; Wang J; Liu Y; Yu Y; Wang L
    Eur J Immunol; 2006 May; 36(5):1324-36. PubMed ID: 16619287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1.
    Lees CJ; Apostolopoulos V; Acres B; Ong CS; Popovski V; McKenzie IF
    Cancer Immunol Immunother; 2000 Feb; 48(11):644-52. PubMed ID: 10663612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parameters for using mannan-MUC1 fusion protein to induce cellular immunity.
    Pietersz GA; Li W; Popovski V; Caruana JA; Apostolopoulos V; McKenzie IF
    Cancer Immunol Immunother; 1998 Feb; 45(6):321-6. PubMed ID: 9490202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen.
    Apostolopoulos V; Karanikas V; Haurum JS; McKenzie IF
    J Immunol; 1997 Dec; 159(11):5211-8. PubMed ID: 9548459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral.
    Apostolopoulos V; Osinski C; McKenzie IF
    Nat Med; 1998 Mar; 4(3):315-20. PubMed ID: 9500605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls.
    Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; van Zanten-Przybysz I; Hummel P; Nijman HW; Kenemans P; Hilgers J
    Cancer Immunol Immunother; 1999 Apr; 48(1):47-55. PubMed ID: 10235488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTL in mice immunized with human mucin 1 are MHC-restricted.
    Apostolopoulos V; Loveland BE; Pietersz GA; McKenzie IF
    J Immunol; 1995 Dec; 155(11):5089-94. PubMed ID: 7594517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice.
    Zhang S; Graeber LA; Helling F; Ragupathi G; Adluri S; Lloyd KO; Livingston PO
    Cancer Res; 1996 Jul; 56(14):3315-9. PubMed ID: 8764127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.